Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R McKay

Showing results (861-870 of 932) with videos related to

Pageof 94
Sort By:
JCO Oncology Practice|December 19, 2024
Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is NowNeal Shore, Sarah M Nielsen, Edward D Esplin, et al.
The Prostate|November 15, 2023
PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectivenessChanning J Paller, Pedro C Barata, Justin Lorentz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 26, 2022
Longitudinal Molecular Profiling of Circulating Tumor Cells in Metastatic Renal Cell CarcinomaMatthew Bootsma, Rana R McKay, Hamid Emamekhoo, et al.
Frontiers in Oncology|April 17, 2023
Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 ("Oligometastatic") and M2 ("Polymetastatic") subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC)Margaret F Meagher, Maria C Mir, Andrea Minervini, et al.
Nature Communications|October 14, 2025
Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panelsKyle T Helzer, Marina N Sharifi, Jamie M Sperger, et al.
JCO Oncology Practice|September 28, 2020
Practical Considerations and Challenges for Germline Genetic Testing in Patients With Prostate Cancer: Recommendations From the Germline Genetics Working Group of the PCCTCBrittany M Szymaniak, Lauren A Facchini, Veda N Giri, et al.
EMBO Molecular Medicine|June 23, 2018
A HIF-LIMD1 negative feedback mechanism mitigates the pro-tumorigenic effects of hypoxiaDaniel E Foxler, Katherine S Bridge, John G Foster, et al.
Cancer Research Communications|December 18, 2023
Pain and Its Association with Survival for Black and White Individuals with Advanced Prostate Cancer in the United StatesEmily M Rencsok, Natalie Slopen, Hannah D McManus, et al.
Science Translational Medicine|April 1, 2026
Historic 1994 influenza vaccine cohorts define breadth of antibody and B cell responses toward future influenza A and B virusesThi H O Nguyen, Isabelle J H Foo, Ruth A Purcell, et al.
JAMA Oncology|October 21, 2021
Clinical Activity and Safety of Cabozantinib for Brain Metastases in Patients With Renal Cell CarcinomaLaure Hirsch, Nieves Martinez Chanza, Subrina Farah, et al.
Pageof 94

Showing results (861-870 of 932) with videos related to

Sort By:
Pageof 94
JCO Oncology Practice|December 19, 2024
Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is NowNeal Shore, Sarah M Nielsen, Edward D Esplin, et al.
The Prostate|November 15, 2023
PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectivenessChanning J Paller, Pedro C Barata, Justin Lorentz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 26, 2022
Longitudinal Molecular Profiling of Circulating Tumor Cells in Metastatic Renal Cell CarcinomaMatthew Bootsma, Rana R McKay, Hamid Emamekhoo, et al.
Frontiers in Oncology|April 17, 2023
Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 ("Oligometastatic") and M2 ("Polymetastatic") subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC)Margaret F Meagher, Maria C Mir, Andrea Minervini, et al.
Nature Communications|October 14, 2025
Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panelsKyle T Helzer, Marina N Sharifi, Jamie M Sperger, et al.
JCO Oncology Practice|September 28, 2020
Practical Considerations and Challenges for Germline Genetic Testing in Patients With Prostate Cancer: Recommendations From the Germline Genetics Working Group of the PCCTCBrittany M Szymaniak, Lauren A Facchini, Veda N Giri, et al.
EMBO Molecular Medicine|June 23, 2018
A HIF-LIMD1 negative feedback mechanism mitigates the pro-tumorigenic effects of hypoxiaDaniel E Foxler, Katherine S Bridge, John G Foster, et al.
Cancer Research Communications|December 18, 2023
Pain and Its Association with Survival for Black and White Individuals with Advanced Prostate Cancer in the United StatesEmily M Rencsok, Natalie Slopen, Hannah D McManus, et al.
Science Translational Medicine|April 1, 2026
Historic 1994 influenza vaccine cohorts define breadth of antibody and B cell responses toward future influenza A and B virusesThi H O Nguyen, Isabelle J H Foo, Ruth A Purcell, et al.
JAMA Oncology|October 21, 2021
Clinical Activity and Safety of Cabozantinib for Brain Metastases in Patients With Renal Cell CarcinomaLaure Hirsch, Nieves Martinez Chanza, Subrina Farah, et al.
Pageof 94